XCSFDHG46767FHJHJF
tdp2664 InvestorPlace Endo Pharmaceuticals (NASDAQ: ENDP ) — This specialty pharma company develops branded and generic prescription drugs used primarily to treat and manage pain and urologic disorders. Its recent acquisitions led fundamental analysts to project a 17% increase in revenues for 2012. And its entry into new therapeutic areas will benefit the company in the future.
No comments:
Post a Comment